MONEAD研究:癫痫孕妇的胎儿丢失与畸形
MONEAD研究为NIH资助的前瞻性多中心观察性研究,纳入2012年12月至2016年1月孕妇,比较癫痫孕妇与健康孕妇的严重不良胎儿结局。癫痫孕妇严重不良胎儿结局发生率7.9%高于健康孕妇1.9%(p=0.025,OR 4.45,95%CI 1.04-19.01),但胎儿丢失和主要先天畸形单独比较无显著差异。
要点
- 癫痫孕妇严重不良胎儿结局风险高于健康孕妇(7.9% vs 1.9%)。
- 胎儿丢失和主要先天畸形单独比较无统计学差异。
- 多数癫痫孕妇妊娠未发生严重不良胎儿结局。
核心结论
- 癫痫孕妇严重不良胎儿结局发生率高于健康孕妇,但胎儿丢失和主要先天畸形单独比较无显著差异。
研究设计与样本
- NIH资助的前瞻性观察性多中心研究,纳入2012年12月至2016年1月的孕妇。
- 癫痫孕妇351例共365次妊娠,健康孕妇105例共109次妊娠。
主要发现
- 严重不良胎儿结局在癫痫孕妇中占7.9%,健康孕妇中占1.9%(p=0.025),OR 4.45(95%CI 1.04-19.01)。
- 胎儿丢失发生率2.8% vs 0%(p=0.126),主要先天畸形5.2% vs 1.9%(p=0.185;OR 2.86,95%CI 0.65-12.53),均无显著差异。
- 癫痫孕妇中胎儿丢失未见与急性发作相关。
- 围受孕叶酸、非计划/意外妊娠、既往孕产史或抗癫痫药物血药浓度不影响结局,但胎儿丢失受多药治疗相关的血药浓度效应影响。
- 母方或父方主要先天畸形家族史与严重不良胎儿结局增加边缘相关(p=0.046)。
临床怎么用
- 癫痫孕妇应关注严重不良胎儿结局风险,但多数妊娠结局良好。
- 抗癫痫药物多药治疗可能影响胎儿丢失风险,需个体化评估。
局限性
- 平均入组孕周组间差异可能影响胎儿丢失结果。
- MONEAD研究未针对这些次要结局设计效能,样本量小限制分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine occurrence of severe adverse fetal outcomes (SAO), including fetal loss and major congenital malformations (MCMs), in pregnant women with epilepsy (PWWE) vs healthy pregnant women (HPW). METHODS: The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study is an NIH-funded, prospective, observational, multicenter investigation of pregnancy outcomes for both mother and child, which enrolled women December 2012 through January 2016. RESULTS: The 351 PWWE had 365 conceptions, and 105 HPW had 109 conceptions. SAOs occurred more often in PWWE (7.9%) vs HPW (1.9%) (p = 0.025) with odds ratio (OR) 4.45 (95% confidence intervals [CI] 1.04-19.01). There were no significant differences for fetal loss (2.8% vs 0%, p = 0.126) or MCMs (5.2% vs 1.9%, p = 0.185; OR 2.86, 95% CI 0.65-12.53) individually. No fetal losses in PWWE appeared to be related to acute seizures. Outcomes were not affected by periconceptional folate, unplanned/unwanted pregnancies, prior maternal pregnancy history, or antiepileptic drug (AED) blood levels, except for an AED level effect for fetal loss that appeared to be due to polytherapy. Combined maternal or paternal family history of MCM was marginally associated with increased SAOs (p = 0.046). CONCLUSIONS: The findings provide additional information on risks of SAOs in PWWE, assessing effects of both AED levels and periconceptional folate. Group differences in average enrollment gestational age could have affected fetal loss results. Analyses are limited by small sample sizes as the MONEAD study was not powered for these secondary outcomes. The large majority of pregnancies in women with epilepsy do not have SOAs.
引用
- Meador KJ, Pennell PB, May RC, et al. Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy. Neurology. 2019. PMID: 31806691. doi:10.1212/WNL.0000000000008687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。